BioSpace News Archive

FUJIFILM Irvine Scientific, Inc., a world leader in providing cell culture solutions for Life Science and Medical markets, today announced the expansion of its Armstrong R&D Center of Excellence at its headquarters in California.

Scipher Medicine, a precision immunology company matching patients with their most effective therapies, announced that Alif Saleh, Chief Executive Officer, and John Strumbos, Chief Financial Officer will present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 18, 2021, at 9:00 a.m. ET, and will participate in one-on-one investor meetings.

UroGen Pharma Ltd. (Nasdaq: URGN), is announcing at its virtual Spotlight Event being held today that, following recent discussions with the U.S. Food and Drug Administration (“FDA”), it plans to conduct a new, single-arm Phase 3 pivotal study of UGN-102 for the treatment of low-grade, intermediate-risk, non-muscle invasive bladder cancer (“NMIBC”).

The fifth annual CNS Summit Innovation Index, compiled by IDEA Pharma, sees Pfizer top the industry.

Wave Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update

Healthcare Triangle Inc today announced that Suresh Venkatachari, Chairman and CEO is scheduled to present virtually at the Credit Suisse 30th Annual Healthcare Conference on Thursday, November 11 at 1:50 pm ET.

Mydecine Innovations Group today announced that Dr. Rakesh Jetly, Chief Medical Officer of Mydecine, will be participating in a panel entitled, “The State of Care and the Case for Psychedelic Therapy” on Wednesday, November 10, 2021 at 7:30 p.m.

Accuray Incorporated (NASDAQ: ARAY) announced today that more than two decades of globally-driven clinical data support the use of the company’s CyberKnife® robotic radiotherapy platform for the delivery of stereotactic radiosurgery (SRS) treatments for neurological diseases.

LYON, France, November 10, 2021 - EDAP TMS SA, the global leader in therapeutic ultrasound, announced that it will release its financial results for the third quarter ended September 30, 2021 after the markets close on Wednesday, November 17, 2021.

Pyxis Oncology, Inc., announced that management will present at and host one-on-one investor meetings during the virtual portion of the Jefferies London Healthcare Conference, taking place November 18-19, 2021.